ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 108 filers reported holding ENDOCYTE INC in Q2 2013. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $23,985,000 | +75.8% | 1,350,481 | +36.6% | 0.01% | +60.0% |
Q2 2018 | $13,644,000 | +22640.0% | 988,731 | +4997.3% | 0.01% | – |
Q1 2016 | $60,000 | -27.7% | 19,397 | -6.5% | 0.00% | – |
Q4 2015 | $83,000 | -46.5% | 20,756 | -38.7% | 0.00% | – |
Q3 2015 | $155,000 | +47.6% | 33,849 | +67.3% | 0.00% | – |
Q2 2015 | $105,000 | -92.0% | 20,232 | -89.8% | 0.00% | -100.0% |
Q2 2014 | $1,313,000 | -44.4% | 199,205 | +101.0% | 0.00% | 0.0% |
Q1 2014 | $2,360,000 | +124.5% | 99,098 | +0.7% | 0.00% | – |
Q4 2013 | $1,051,000 | +465.1% | 98,423 | +603.6% | 0.00% | – |
Q3 2013 | $186,000 | -88.6% | 13,989 | -88.7% | 0.00% | -100.0% |
Q2 2013 | $1,630,000 | – | 124,103 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 4,211,302 | $74,793,000 | 19.97% |
VHCP Management III, LLC | 600,000 | $10,656,000 | 8.05% |
RA Capital Management | 6,196,143 | $110,043,000 | 5.88% |
GREAT POINT PARTNERS LLC | 1,606,100 | $28,524,000 | 4.44% |
Avoro Capital Advisors LLC | 5,301,718 | $94,159,000 | 4.32% |
Ghost Tree Capital, LLC | 1,100,000 | $19,536,000 | 4.15% |
Crosspoint Capital Strategies, LLC | 104,573 | $1,857,000 | 3.04% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,514,084 | $62,410,000 | 2.24% |
NEXTHERA CAPITAL LP | 654,532 | $11,624,000 | 2.23% |
EMORY UNIVERSITY | 148,628 | $2,640,000 | 1.73% |